Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PCDHA9 CDHR3 PECAM1 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	3.19e-07	187	100	9	GO:0007156
GeneOntologyBiologicalProcess	Golgi to plasma membrane protein transport	ANK3 NSF GGA3 MACF1 KIF13A	2.54e-06	45	100	5	GO:0043001
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	PCDHA9 CDHR3 PECAM1 PCDHA13 GRID2 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	2.91e-06	313	100	10	GO:0098742
GeneOntologyBiologicalProcess	Golgi to plasma membrane transport	ANK3 NSF GGA3 MACF1 KIF13A	2.28e-05	70	100	5	GO:0006893
GeneOntologyBiologicalProcess	post-Golgi vesicle-mediated transport	WIPI1 ANK3 NSF GGA3 MACF1 KIF13A	2.49e-05	119	100	6	GO:0006892
GeneOntologyBiologicalProcess	establishment of protein localization to plasma membrane	ANK3 NSF GGA3 MACF1 KIF13A	3.41e-05	76	100	5	GO:0061951
GeneOntologyBiologicalProcess	cell-cell adhesion	PCDHA9 ANK3 CDHR3 PECAM1 CD55 PCDHA13 GRID2 PCDHA3 PCDHA2 EBI3 PCDH19 PCDH11X IZUMO1 DUSP10 CDH3 CDON	5.87e-05	1077	100	16	GO:0098609
GeneOntologyBiologicalProcess	retina development in camera-type eye	HIPK1 TTLL5 CASZ1 ALMS1 SCAPER CDON IMPG2	7.60e-05	211	100	7	GO:0060041
GeneOntologyBiologicalProcess	retina morphogenesis in camera-type eye	HIPK1 CASZ1 ALMS1 CDON IMPG2	7.68e-05	90	100	5	GO:0060042
Domain	CADHERIN_1	PCDHA9 CDHR3 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	1.77e-07	113	101	8	PS00232
Domain	Cadherin	PCDHA9 CDHR3 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	1.77e-07	113	101	8	PF00028
Domain	CADHERIN_2	PCDHA9 CDHR3 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	1.90e-07	114	101	8	PS50268
Domain	-	PCDHA9 CDHR3 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	1.90e-07	114	101	8	2.60.40.60
Domain	CA	PCDHA9 CDHR3 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	2.03e-07	115	101	8	SM00112
Domain	Cadherin-like	PCDHA9 CDHR3 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	2.17e-07	116	101	8	IPR015919
Domain	Cadherin	PCDHA9 CDHR3 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	2.48e-07	118	101	8	IPR002126
Domain	Cadherin_2	PCDHA9 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X	1.37e-06	65	101	6	PF08266
Domain	Cadherin_N	PCDHA9 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X	1.37e-06	65	101	6	IPR013164
Domain	Cadherin_CS	PCDHA9 PCDHA13 PCDHA3 PCDHA2 PCDH19 PCDH11X CDH3	2.08e-06	109	101	7	IPR020894
Domain	Cadherin_tail	PCDHA9 PCDHA13 PCDHA3 PCDHA2	4.64e-05	37	101	4	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHA13 PCDHA3 PCDHA2	4.64e-05	37	101	4	IPR031904
Domain	SEA	MUC16 MUC3A IMPG2	5.35e-05	14	101	3	SM00200
Domain	ALMS_motif	ALMS1 CEP295	8.66e-05	3	101	2	IPR029299
Domain	ALMS_motif	ALMS1 CEP295	8.66e-05	3	101	2	PF15309
Domain	Vitellinogen_superhlx	CAND1 APOB	8.66e-05	3	101	2	IPR011030
Domain	SEA	MUC16 MUC3A IMPG2	2.51e-04	23	101	3	PS50024
Domain	SEA_dom	MUC16 MUC3A IMPG2	2.51e-04	23	101	3	IPR000082
Domain	IG_LIKE	PECAM1 SLAMF6 LRIG1 IGHM VCAN SIGLEC10 IZUMO1 LRIT1 CDON	1.37e-03	491	101	9	PS50835
Domain	Ig-like_dom	PECAM1 SLAMF6 LRIG1 IGHM VCAN SIGLEC10 IZUMO1 LRIT1 CDON	1.62e-03	503	101	9	IPR007110
Domain	IG	PECAM1 SLAMF6 LRIG1 VCAN SIGLEC10 IZUMO1 LRIT1 CDON	2.03e-03	421	101	8	SM00409
Domain	Ig_sub	PECAM1 SLAMF6 LRIG1 VCAN SIGLEC10 IZUMO1 LRIT1 CDON	2.03e-03	421	101	8	IPR003599
Domain	HEAT	CAND1 ECPAS MMS19	2.23e-03	48	101	3	PF02985
Domain	-	MUC16 IMPG2	2.90e-03	15	101	2	3.30.70.960
Domain	HEAT	CAND1 ECPAS MMS19	3.82e-03	58	101	3	IPR000357
Domain	Iontro_rcpt	GRIA4 GRID2	4.19e-03	18	101	2	IPR001320
Domain	Lig_chan-Glu_bd	GRIA4 GRID2	4.19e-03	18	101	2	PF10613
Domain	Iono_rcpt_met	GRIA4 GRID2	4.19e-03	18	101	2	IPR001508
Domain	Glu/Gly-bd	GRIA4 GRID2	4.19e-03	18	101	2	IPR019594
Domain	Lig_chan-Glu_bd	GRIA4 GRID2	4.19e-03	18	101	2	SM00918
Domain	Lig_chan	GRIA4 GRID2	4.19e-03	18	101	2	PF00060
Domain	PBPe	GRIA4 GRID2	4.19e-03	18	101	2	SM00079
Domain	Ig-like_fold	PECAM1 SLAMF6 LRIG1 EBI3 IGHM VCAN SIGLEC10 IZUMO1 LRIT1 CDON	4.87e-03	706	101	10	IPR013783
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC15 MUC16 MUC3A	8.34e-05	16	77	3	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC15 MUC16 MUC3A	1.01e-04	17	77	3	M27412
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	PEG3 BACH1 ATF6B KLF10 NKX2-4 ATXN1 NKX2-1 BRPF1 SCAPER PXN ZNF99 EPAS1 PARP12 MYB ZNF292	1.46e-08	808	102	15	20412781
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA9 PCDHA13 PCDHA3 PCDHA2	9.28e-08	15	102	4	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA9 PCDHA13 PCDHA3 PCDHA2	1.61e-07	17	102	4	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA9 PCDHA13 PCDHA3 PCDHA2	2.07e-07	18	102	4	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA9 PCDHA13 PCDHA3 PCDHA2	2.07e-07	18	102	4	10662547
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TTLL5 ECPAS GGA3 PHKB ESYT2 SUGT1 ALMS1 N4BP2 BRPF1 PXN COBL CEP295 CEP97 ARHGAP21	2.07e-07	853	102	14	28718761
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	HIPK1 CASZ1 ALMS1 SCAPER PCDH11X CEP295 USP33 ZNF292	4.59e-07	233	102	8	37704626
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA9 PCDHA13 PCDHA3 PCDHA2	7.08e-07	24	102	4	24698270
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHA9 PCDHA13 PCDHA3 PCDHA2 NKX2-1	7.29e-07	57	102	5	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHA9 PCDHA13 PCDHA3 PCDHA2 NKX2-1	7.96e-07	58	102	5	30377227
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA9 PCDHA13 PCDHA3 PCDHA2	1.35e-06	28	102	4	15347688
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	WIPI1 PCDHA9 PCDHA13 PCDHA3 PCDHA2 PCDH11X	1.46e-06	119	102	6	28625976
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA9 PCDHA13 PCDHA3 PCDHA2 PCDH11X	2.70e-06	74	102	5	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHA9 PCDHA13 PCDHA3 PCDHA2 PCDH11X	3.28e-06	77	102	5	10835267
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HIPK1 PEG3 GGA3 CRACD PCDH19 COBL MACF1 ARHGAP21 USP33	3.31e-06	407	102	9	12693553
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA9 PCDHA13 PCDHA3 PCDHA2 PCDH11X	3.97e-06	80	102	5	10716726
Pubmed	The protein interaction landscape of the human CMGC kinase group.	CAND1 POLB HIPK1 BACH1 NEB CRHR1 ESYT2 ALMS1 AFF1 CEP97 NLK	6.44e-06	695	102	11	23602568
Pubmed	HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.	HIPK1 MYB	8.52e-06	2	102	2	19646965
Pubmed	USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells.	EPAS1 USP33	8.52e-06	2	102	2	35191554
Pubmed	The up-regulation of Myb may help mediate EGCG inhibition effect on mouse lung adenocarcinoma.	PEG3 MYB	8.52e-06	2	102	2	27461468
Pubmed	Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1.	ATXN1 NLK	8.52e-06	2	102	2	23719801
Pubmed	The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling.	PECAM1 EPAS1	8.52e-06	2	102	2	10880563
Pubmed	Myb expression is critical for myeloid leukemia development induced by Setbp1 activation.	SETBP1 MYB	8.52e-06	2	102	2	27863435
Pubmed	A technique to improve diagnostic information from fine-needle aspirations: immunohistochemistry on cytoscrape.	NKX2-1 MUC3A	8.52e-06	2	102	2	19365834
Pubmed	Nemo-like kinase associated with proliferation and apoptosis by c-Myb degradation in breast cancer.	NLK MYB	8.52e-06	2	102	2	23935942
Pubmed	ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits.	ALMS1 CEP295	8.52e-06	2	102	2	30421101
Pubmed	Functional proteomics mapping of a human signaling pathway.	ANK3 HIPK1 PECAM1 GGA3 KLF10 EBI3 AFF1 MACF1 KIF13A EPAS1	9.77e-06	591	102	10	15231748
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	UBAP2 JMJD1C PAPOLG SUGT1 ALMS1 TEX264 GUSB N4BP2 CEP295 PRR14L USP33	1.06e-05	733	102	11	34672954
Pubmed	Tissue distribution and subcellular localization of the family of Kidney Ankyrin Repeat Domain (KANK) proteins.	PECAM1 NKX2-1 PXN	1.33e-05	16	102	3	33253712
Pubmed	A human MAP kinase interactome.	ANK3 HIPK1 NEB ATXN1 N4BP2 COBL MACF1 DUSP10 EPAS1	1.37e-05	486	102	9	20936779
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	PEG3 NEB JMJD1C KLF10 ALMS1 ATXN1 PXN MACF1 ARHGAP21	1.63e-05	497	102	9	23414517
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ANK3 BACH1 POLRMT NEB ECPAS COBL ZNF99 ARHGAP21 ZNF292	1.63e-05	497	102	9	36774506
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ANK3 PEG3 CD55 APOB PHKB TEX264 VCAN AFF1 MACF1 CEP295 KIF13A ARHGAP21 PARP12	1.75e-05	1084	102	13	11544199
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC15 MUC16 MUC3A	1.94e-05	18	102	3	18834073
Pubmed	Ethanol itself is a holoprosencephaly-inducing teratogen.	NKX2-1 CDON	2.55e-05	3	102	2	28441416
Pubmed	Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.	PECAM1 VCAN	2.55e-05	3	102	2	10930438
Pubmed	Adaptor protein complex-4 (AP-4) is expressed in the central nervous system neurons and interacts with glutamate receptor delta2.	GRID2 CACNG3	2.55e-05	3	102	2	14572453
Pubmed	Centriolar association of ALMS1 and likely centrosomal functions of the ALMS motif-containing proteins C10orf90 and KIAA1731.	ALMS1 CEP295	2.55e-05	3	102	2	20844083
Pubmed	GLIPR1L1 is an IZUMO-binding protein required for optimal fertilization in the mouse.	IZUMO1 GLIPR1L1	2.55e-05	3	102	2	31672133
Pubmed	B cells promote CD8 T cell primary and memory responses to subunit vaccines.	EBI3 IGHM	2.55e-05	3	102	2	34433030
Pubmed	TTF-1/Nkx2.1 functional connection with mutated EGFR relies on LRIG1 and β-catenin pathways in lung cancer cells.	LRIG1 NKX2-1	2.55e-05	3	102	2	30314701
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ANK3 NSF MRPL47 TTLL5 BACH1 POLRMT ATF6B ESYT2 RAB3GAP1 SUGT1 TEX264 GUSB N4BP2 MACF1 USP33	2.87e-05	1487	102	15	33957083
Pubmed	Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes.	GRIA4 APOB CRHR1 GUSB MYB	2.98e-05	121	102	5	8827514
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	ESYT2 ALMS1 COBL MACF1 CEP97 ARHGAP21	3.65e-05	209	102	6	36779422
Pubmed	Network organization of the human autophagy system.	WIPI1 CAND1 NSF RBBP7 POLRMT ECPAS ESYT2 RAB3GAP1	4.56e-05	437	102	8	20562859
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	UBAP2 RBBP7 BACH1 ESYT2 ALMS1 ATXN1 N4BP2 COBL MACF1 KIF13A ARHGAP21	4.62e-05	861	102	11	36931259
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHA9 PCDHA13 PCDHA3 PCDHA2	4.92e-05	68	102	4	11230163
Pubmed	Rescue of holoprosencephaly in fetal alcohol-exposed Cdon mutant mice by reduced gene dosage of Ptch1.	NKX2-1 CDON	5.09e-05	4	102	2	24244464
Pubmed	Protein complex interactor analysis and differential activity of KDM3 subfamily members towards H3K9 methylation.	KDM3A JMJD1C	5.09e-05	4	102	2	23593242
Pubmed	Involvement of vessels and PDGFB in muscle splitting during chick limb development.	PECAM1 EPAS1	5.09e-05	4	102	2	17553906
Pubmed	Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.	NLK MYB	5.09e-05	4	102	2	15082531
Pubmed	Cool-associated Tyrosine-phosphorylated Protein 1 Is Required for the Anchorage-independent Growth of Cervical Carcinoma Cells by Binding Paxillin and Promoting AKT Activation.	GGA3 PXN	5.09e-05	4	102	2	28100775
Pubmed	Transcription factor and microRNA interactions in lung cells: an inhibitory link between NK2 homeobox 1, miR-200c and the developmental and oncogenic factors Nfib and Myb.	NKX2-1 MYB	5.09e-05	4	102	2	25763778
Pubmed	Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis?	MUC16 NKX2-1	5.09e-05	4	102	2	17413979
Pubmed	Relief of hypoxia by angiogenesis promotes neural stem cell differentiation by targeting glycolysis.	PECAM1 NEUROG1 EPAS1	6.06e-05	26	102	3	26856890
Pubmed	Tagging genes with cassette-exchange sites.	NSF PECAM1 GGA3 PHKB MACF1 MMS19 ZNF292	6.10e-05	335	102	7	15741177
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHA9 PCDHA13 PCDHA3 PCDHA2	6.15e-05	72	102	4	10380929
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	PCDHA9 PCDHA13 PCDHA3 PCDHA2	7.22e-05	75	102	4	15372022
Pubmed	Biological, clinical and population relevance of 95 loci for blood lipids.	APOB JMJD1C RAB3GAP1 AFF1 MACF1	7.31e-05	146	102	5	20686565
Pubmed	Wnt7b stimulates embryonic lung growth by coordinately increasing the replication of epithelium and mesenchyme.	PECAM1 NKX2-1 EPAS1	7.61e-05	28	102	3	18367557
Pubmed	Transcriptional corepressors HIPK1 and HIPK2 control angiogenesis via TGF-β-TAK1-dependent mechanism.	HIPK1 PECAM1 NKX2-1	8.47e-05	29	102	3	23565059
Pubmed	Differential sensitivity of v-Myb and c-Myb to Wnt-1-induced protein degradation.	NLK MYB	8.47e-05	5	102	2	15308626
Pubmed	B Lymphocyte-Derived CCL7 Augments Neutrophil and Monocyte Recruitment, Exacerbating Acute Kidney Injury.	IGHM SIGLEC10	8.47e-05	5	102	2	32737150
Pubmed	Axon initial segment-associated microglia.	ANK3 VCAN	8.47e-05	5	102	2	25653382
Pubmed	Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease.	PCDHA9 PECAM1	8.47e-05	5	102	2	34888534
Pubmed	A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing.	IGHM SIGLEC10	8.47e-05	5	102	2	21623346
Pubmed	Lung Kruppel-like factor, a zinc finger transcription factor, is essential for normal lung development.	PECAM1 NKX2-1	8.47e-05	5	102	2	10409672
Pubmed	B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer.	EBI3 IGHM	8.47e-05	5	102	2	35046933
Pubmed	Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.	NSF CRHR1	8.47e-05	5	102	2	15293277
Pubmed	Regional expression of the homeobox gene Nkx-2.2 in the developing mammalian forebrain.	NKX2-4 NKX2-1	8.47e-05	5	102	2	1346742
Pubmed	Yolk sac macrophage progenitors traffic to the embryo during defined stages of development.	PECAM1 MYB	8.47e-05	5	102	2	29311541
Pubmed	Calcium-permeable AMPA receptor plasticity is mediated by subunit-specific interactions with PICK1 and NSF.	NSF GRIA4	8.47e-05	5	102	2	15797551
Pubmed	Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells.	IGHM SIGLEC10	8.47e-05	5	102	2	26947073
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	JMJD1C N4BP2 PCDH19 PCDH11X ARHGAP21	9.12e-05	153	102	5	10718198
Pubmed	Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.	WIPI1 APOB JMJD1C	9.39e-05	30	102	3	19936222
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	CAND1 UBAP2 RBBP7 GGA3 CRACD SUGT1 ALMS1 MACF1 PRR14L ARHGAP21 PARP12	9.53e-05	934	102	11	33916271
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM3A CAND1 MCHR1 ANK3 HIPK1 TTLL5 PEG3 BACH1 MACF1 USPL1 ARHGAP21 USP33 ZNF292	9.97e-05	1285	102	13	35914814
Pubmed	Interaction proteomics identify NEURL4 and the HECT E3 ligase HERC2 as novel modulators of centrosome architecture.	CAND1 SUGT1 CEP97	1.04e-04	31	102	3	22261722
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	RBBP7 POLB ECPAS CRACD VCAN PXN MACF1 ARHGAP21	1.13e-04	498	102	8	36634849
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CAND1 ANK3 ECPAS JMJD1C CASZ1 PHKB ESYT2 ATXN1 SETBP1 COBL AFF1 MACF1 ASPSCR1 NLK	1.15e-04	1489	102	14	28611215
Pubmed	The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3.	NLK MYB	1.27e-04	6	102	2	16055500
Pubmed	c-Myb Exacerbates Atherosclerosis through Regulation of Protective IgM-Producing Antibody-Secreting Cells.	IGHM MYB	1.27e-04	6	102	2	31116977
Pubmed	Expression of Islet1 in thyroid development related to budding, migration, and fusion of primordia.	PECAM1 NKX2-1	1.27e-04	6	102	2	18985716
Pubmed	Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis.	PECAM1 PXN	1.27e-04	6	102	2	20011539
Pubmed	Identification of proteins that interact with BRCA1 by Far-Western library screening.	RBBP7 PEG3	1.27e-04	6	102	2	11746496
Pubmed	Activity-Dependent Gating of Parvalbumin Interneuron Function by the Perineuronal Net Protein Brevican.	GRIA4 NKX2-1	1.27e-04	6	102	2	28712654
Pubmed	Knockout of insulin-like growth factor-1 receptor impairs distal lung morphogenesis.	PECAM1 NKX2-1	1.27e-04	6	102	2	23139760
Pubmed	Phenotype and hematopoietic potential of side population cells throughout embryonic development.	PECAM1 ATXN1	1.27e-04	6	102	2	12805065
Pubmed	USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110.	CEP97 USP33	1.27e-04	6	102	2	23486064
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ANK3 JMJD1C GGA3 ALMS1 MACF1 ARHGAP21	1.30e-04	263	102	6	34702444
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	PXN MACF1 ARHGAP21	1.77e-04	37	102	3	27565344
Pubmed	Glutamate receptor δ2 is essential for input pathway-dependent regulation of synaptic AMPAR contents in cerebellar Purkinje cells.	GRIA4 GRID2	1.77e-04	7	102	2	21368048
Pubmed	Cdo functions at multiple points in the Sonic Hedgehog pathway, and Cdo-deficient mice accurately model human holoprosencephaly.	NKX2-1 CDON	1.77e-04	7	102	2	16647303
Pubmed	Inhibitor of differentiation 1 promotes endothelial survival in a bleomycin model of lung injury in mice.	PECAM1 NKX2-1	1.77e-04	7	102	2	17717145
Pubmed	The 22q11 deletion syndrome candidate gene Tbx1 determines thyroid size and positioning.	PECAM1 NKX2-1	1.77e-04	7	102	2	17164259
Pubmed	TARP γ-2 and γ-8 Differentially Control AMPAR Density Across Schaffer Collateral/Commissural Synapses in the Hippocampal CA1 Area.	GRIA4 CACNG3	1.77e-04	7	102	2	27076426
Pubmed	Interleukin-35 induces regulatory B cells that suppress autoimmune disease.	EBI3 IGHM	1.77e-04	7	102	2	24743305
Pubmed	Systemic inactivation of Hs6st1 in mice is associated with late postnatal mortality without major defects in organogenesis.	PECAM1 NKX2-1	1.77e-04	7	102	2	18196599
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	TTLL5 JMJD1C SUGT1 ALMS1 ATXN1	2.16e-04	184	102	5	32908313
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NSF HIPK1 POLRMT SNX33 ECPAS JMJD1C CASZ1 CRACD ESYT2 MMS19	2.16e-04	857	102	10	25609649
Interaction	PCDHA10 interactions	PCDHA9 PCDHA13 PCDHA3 PCDHA2	3.60e-06	22	98	4	int:PCDHA10
Interaction	ZYX interactions	CAND1 CRACD ALMS1 ATXN1 N4BP2 PXN COBL MACF1 CEP97 ARHGAP21	4.61e-06	329	98	10	int:ZYX
Interaction	AP2B1 interactions	GGA3 RAB3GAP1 CFAP54 ALMS1 ATXN1 N4BP2 PXN MMS19 KIF13A CEP97	1.38e-05	373	98	10	int:AP2B1
Interaction	CNOT9 interactions	UBAP2 PCDHA3 JMJD1C ALMS1 N4BP2 IZUMO1 CEP97 MYB	1.71e-05	231	98	8	int:CNOT9
Interaction	NLK interactions	BACH1 ATXN1 CEP97 NLK MYB	2.31e-05	70	98	5	int:NLK
Interaction	FLT3 interactions	WIPI1 PCDHA9 PCDHA13 PCDHA3 PCDHA2 APOB ECPAS PCDH11X MMS19	2.49e-05	318	98	9	int:FLT3
Interaction	CNOT2 interactions	UBAP2 JMJD1C SUGT1 ALMS1 ATXN1 N4BP2 NLK	2.62e-05	178	98	7	int:CNOT2
Cytoband	5q31	PCDHA9 PCDHA13 PCDHA3 PCDHA2	1.31e-04	115	102	4	5q31
Cytoband	6p23	ATXN1 KIF13A	5.04e-04	15	102	2	6p23
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHA9 PCDHA13 PCDHA3 PCDHA2 NEUROG1	5.55e-04	298	102	5	chr5q31
GeneFamily	CD molecules\|Mucins	MUC15 MUC16 MUC3A	7.65e-05	21	72	3	648
GeneFamily	Clustered protocadherins	PCDHA9 PCDHA13 PCDHA3 PCDHA2	1.23e-04	64	72	4	20
GeneFamily	Non-clustered protocadherins	PCDH19 PCDH11X	1.01e-03	12	72	2	21
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	ANK3 BACH1 JMJD1C ESYT2 ATXN1 AFF1 NLK ZNF292	4.60e-06	240	102	8	M39236
Coexpression	GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP	CDHR3 SNX33 LRIG1 ATXN1 DUSP10 CEP97 MVD	1.27e-05	198	102	7	M6522
Coexpression	JAK2_DN.V1_DN	NSUN6 MACF1 CEP295 KIF13A CDH3 CEP97	2.43e-05	147	102	6	M2872
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL	WIPI1 MUC15 MUC16 CASZ1 VCAN EPAS1 MYB	2.98e-05	226	102	7	M45709
Coexpression	GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN	NEB VCAN SETBP1 ARHGAP21 PARP12 MYB	3.78e-05	159	102	6	M2979
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	KDM3A IGHM SETBP1 COBL MACF1	3.92e-05	97	102	5	M14698
Coexpression	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	PEG3 LRIG1 VCAN COBL	5.07e-05	52	102	4	M19766
CoexpressionAtlas	alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2	PECAM1 CD55 PAPOLG ESYT2 SLAMF6 LRIG1 MACF1 DUSP10 CEP97 NLK	3.32e-06	327	100	10	GSM538380_500
CoexpressionAtlas	alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2	PECAM1 ESYT2 SLAMF6 LRIG1 N4BP2 DUSP10 CEP97 NLK CDON MYB	3.41e-06	328	100	10	GSM605756_500
CoexpressionAtlas	alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3	PECAM1 CD55 ESYT2 SLAMF6 LRIG1 DUSP10 CEP97 NLK CDON MYB	4.23e-06	336	100	10	GSM605758_500
CoexpressionAtlas	CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4	CD55 ESYT2 SLAMF6 LRIG1 MACF1 DUSP10 CEP97 NLK	6.84e-06	210	100	8	GSM403995_500
CoexpressionAtlas	alpha beta T cells, T.4FP3-.Sp, 4+ 8- GFP- 44lo, Spleen, avg-3	PECAM1 CD55 ESYT2 SLAMF6 LRIG1 DUSP10 CEP97 EPAS1 NLK CDON	8.53e-06	364	100	10	GSM605766_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1	CD55 PAPOLG ESYT2 SLAMF6 MACF1 DUSP10 CEP97 NLK ZNF292	3.00e-05	336	100	9	GSM538413_500
CoexpressionAtlas	alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3	PECAM1 CD55 SLAMF6 LRIG1 DUSP10 CEP97 EPAS1 NLK CDON	3.15e-05	338	100	9	GSM605763_500
CoexpressionAtlas	CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1	PECAM1 CD55 ESYT2 SLAMF6 LRIG1 MACF1 DUSP10 CEP97 NLK	3.15e-05	338	100	9	GSM403987_500
CoexpressionAtlas	alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3	KDM3A BACH1 SLAMF6 LRIG1 AFF1 DUSP10 USPL1 CEP97 MYB	3.53e-05	343	100	9	GSM399400_500
CoexpressionAtlas	alpha beta T cells, T.4Mem44h62l.LN, CD4 TCRb CD44hi CD62Llo, Lymph Node, avg-3	CD55 ESYT2 SLAMF6 LRIG1 DUSP10 CEP97 NLK CDON MYB	3.78e-05	346	100	9	GSM538368_500
CoexpressionAtlas	alpha beta T cells, T.4Mem.LN, TCRb CD44high CD122lo CD4, Lymph Node, avg-3	PECAM1 ESYT2 SLAMF6 LRIG1 DUSP10 CEP97 NLK CDON MYB	3.95e-05	348	100	9	GSM538362_500
CoexpressionAtlas	CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1	PECAM1 CD55 ESYT2 SLAMF6 LRIG1 DUSP10 CEP97 NLK CDON	4.81e-05	357	100	9	GSM403986_500
CoexpressionAtlas	CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3	PECAM1 CD55 ESYT2 SLAMF6 LRIG1 DUSP10 CEP97 NLK CDON	5.02e-05	359	100	9	GSM404000_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	PEG3 CD55 MUC16 GRIA4 VCAN CDH3	8.66e-05	153	100	6	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2	CD55 ESYT2 SLAMF6 LRIG1 MACF1 CEP97 CDON	9.23e-05	224	100	7	GSM403994_500
CoexpressionAtlas	alpha beta T cells, T.4Nve.LN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3	PECAM1 CD55 SLAMF6 LRIG1 DUSP10 CEP97 NLK CDON	1.90e-04	336	100	8	GSM538374_500
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500	KDM3A PEG3 CD55 MUC16 VCAN PCDH11X AFF1 DUSP10 CDH3	2.18e-04	436	100	9	gudmap_dev gonad_e11.5_F_GonMes_Sma_500
CoexpressionAtlas	alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3	PECAM1 CD55 SLAMF6 LRIG1 DUSP10 CEP97 EPAS1 NLK	2.71e-04	354	100	8	GSM605753_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_200	CD55 MUC16 CDH3	3.05e-04	28	100	3	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_200
CoexpressionAtlas	alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3	BACH1 SLAMF6 LRIG1 AFF1 DUSP10 USPL1 CEP97 MYB	3.45e-04	367	100	8	GSM399391_500
CoexpressionAtlas	CD positive, CD4 Test CJ, 4+8-B220-, Spleen, avg-2	CD55 ESYT2 SLAMF6 LRIG1 DUSP10 CEP97 NLK	3.62e-04	280	100	7	GSM404003_500
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ATF6B JMJD1C PAPOLG SCAPER MACF1 ZNF292	6.94e-07	135	102	6	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR3 GRIA4 GRID2 CFAP54 CFAP92 LRIG1	4.19e-06	184	102	6	6b0c110d8930df99043c3b99cf4d873985126960
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR3 GRIA4 GRID2 CFAP54 CFAP92 LRIG1	4.19e-06	184	102	6	35928fc5f7bbf8c7b09181a2bd27e22dff42ec16
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 NSF POLB MUC16 COBL KIF13A	4.60e-06	187	102	6	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 JMJD1C ATXN1 SETBP1 SCAPER MACF1	5.35e-06	192	102	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NSF BACH1 CD55 JMJD1C IGHM SETBP1	5.68e-06	194	102	6	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	mild-dn_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SLC6A16 ESYT2 SLAMF6 ATXN1 CEP97 MYB	6.20e-06	197	102	6	07a1f59c83b748825e0708cd1cc7b63a2cb856cc
ToppCell	Bronchial-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 MUC15 MUC16 LRIG1 NKX2-1 COBL	6.76e-06	200	102	6	d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCell	Healthy_Control-Myeloid-Macrophages-FCN1_high\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	CRACD EBI3 VCAN SETBP1 SIGLEC10	2.89e-05	155	102	5	cd2ccb4632713b4def3a1064599b78207e2e44c0
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POLRMT CD55 PAPOLG RAB3GAP1 CEP97	3.27e-05	159	102	5	74655c22e9fdd88e3052b9dfb954c8fb678bd2d8
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	UBAP2 TTLL5 PECAM1 GRIA4 MANSC4	4.13e-05	167	102	5	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SNX33 ALMS1 COBL PRR14L CDH3	4.25e-05	168	102	5	08f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PCDHA2 NEB CFAP54 MACF1 MANSC4	4.37e-05	169	102	5	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	HIPK1 APOB JMJD1C ATXN1 MACF1	4.63e-05	171	102	5	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Control-CD4+_T_activated\|Control / Disease group and Cell class	KDM3A CFAP54 EBI3 VCAN SIGLEC10	5.02e-05	174	102	5	2b683e81b315ad22555314433aed5681feb48da8
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	POLB TTLL5 SLAMF6 SETBP1 MYB	5.02e-05	174	102	5	2274648b80dd74f3c948a779bba3391095964c34
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB PAPOLG SLAMF6 COBL ZNF292	5.16e-05	175	102	5	a2adaa09f37e3db5d819e56ed402fe04b72abeb2
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB PAPOLG SLAMF6 COBL ZNF292	5.16e-05	175	102	5	59a8481a3b4ed63b137baea25bc02f2078dc3ac7
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 CASZ1 GPR179 LRIG1 NKX2-1	5.30e-05	176	102	5	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 MUC16 CASZ1 MACF1 ARHGAP21	5.75e-05	179	102	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK3 CD55 NKX2-1 COBL CDH3	6.06e-05	181	102	5	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	ANK3 JMJD1C LRIG1 ATXN1 MACF1	6.06e-05	181	102	5	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	PND07-28-samps-Epithelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ANK3 CDHR3 CD55 NKX2-1 COBL	6.38e-05	183	102	5	a98f1d71d82ed6cca996f74352ab834fb6e95206
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDHR3 CRACD NKX2-1 LRIT1 MYB	6.55e-05	184	102	5	ae0a77e3e520a246b17776bb19503519636b02ee
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD55 GRID2 ATXN1 VCAN PCDH11X	7.07e-05	187	102	5	173f029dcf32af008f517912f6d110a33a9e98cf
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ANK3 CD55 CASZ1 NKX2-1 COBL	7.25e-05	188	102	5	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDHR3 GRIA4 CRACD NKX2-1 MYB	7.25e-05	188	102	5	3139540a656c0436b2123ea50741ff8d00112165
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDHR3 GRIA4 CRACD NKX2-1 MYB	7.43e-05	189	102	5	222e67d3fd106c43b0cae6538dddeaa7be1f759f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 ESYT2 ATXN1 MACF1 ZNF292	7.62e-05	190	102	5	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CASZ1 LRIG1 SETBP1 CDH3 CDON	7.62e-05	190	102	5	e102622f05c7f3e1bd8b224ea159d57033793ee0
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CASZ1 LRIG1 SETBP1 CDH3 CDON	7.81e-05	191	102	5	de2cd94ee88a7754f86d39469e38374d668210c7
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A16 CRACD PCDH19 PCDH11X DUSP10	7.81e-05	191	102	5	de54dab85db70f847de75b3b6d7667a0e13b9bfb
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	MCHR1 PECAM1 VCAN SETBP1 PCDH11X	8.00e-05	192	102	5	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ANK3 HIPK1 JMJD1C ESYT2 MACF1	8.00e-05	192	102	5	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	moderate-Lymphoid-B_cell\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	BACH1 CD55 EBI3 SETBP1 SIGLEC10	8.00e-05	192	102	5	ae3727503c3b9f4695e565fd3161cc33b898f349
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRID2 CRACD PCDH11X DUSP10 CDH3	8.20e-05	193	102	5	2c15186d15545804cc262da9137ab825609d4b2c
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	CAND1 APOOL N4BP2 AFF1 CEP97	8.20e-05	193	102	5	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRID2 CRACD PCDH11X DUSP10 CDH3	8.20e-05	193	102	5	8b77625bf3c87d39767fb391d1beaca4ab02342b
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	SLC26A3 PECAM1 SETBP1 PCDH11X EPAS1	8.40e-05	194	102	5	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	ANK3 CDHR3 CFAP54 LRIG1 COBL	8.61e-05	195	102	5	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	ANK3 CDHR3 CFAP54 LRIG1 COBL	8.61e-05	195	102	5	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ANK3 CDHR3 CFAP54 COBL MACF1	8.82e-05	196	102	5	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ANK3 CDHR3 CFAP54 COBL MACF1	8.82e-05	196	102	5	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Stromal-Fibroblast\|Stromal / Disease state, Lineage and Cell class	CD55 ESYT2 VCAN PXN CDON	8.82e-05	196	102	5	4930eeb303d174c28fd91021723e26fdf1af9170
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	ANK3 PCDH11X ASPSCR1 CDH3 CDON	9.03e-05	197	102	5	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	ESYT2 SLAMF6 SETBP1 MACF1 PARP12	9.25e-05	198	102	5	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	Control-PLT_4\|Control / Disease Group and Platelet Clusters	BACH1 CD55 JMJD1C SLAMF6 BEND7	9.25e-05	198	102	5	387fd3037fd52e4d4c42de0588767e58af228b59
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	SLC26A3 ANK3 ATXN1 SCAPER KIF13A	9.25e-05	198	102	5	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	SLC26A3 ANK3 ATXN1 SCAPER AFF1	9.47e-05	199	102	5	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	ANK3 VCAN SCAPER ARHGAP21 ZNF292	9.69e-05	200	102	5	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	ASK440-Epithelial\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	ANK3 MUC15 CDHR3 CD55 NKX2-1	9.69e-05	200	102	5	cb617e2a0ca82b470b473b8d5906bc8879c85718
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Hpcal4_(Substantia_Innominata_(SI))\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A16 MUC15 APOB	1.31e-04	43	102	3	f1e6e1c386851e773f8aa44f112ebf7fdb887df1
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Hpcal4_(Substantia_Innominata_(SI))--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A16 MUC15 APOB	1.31e-04	43	102	3	05de4f11e7315dce19efed14605d7e1704d61b3a
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Hpcal4_(Substantia_Innominata_(SI))-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC6A16 MUC15 APOB	1.31e-04	43	102	3	ba1a8fd3119a26b65722898276045bf5ecf59768
Disease	1,5 anhydroglucitol measurement	PCDHA9 PCDHA13 PCDHA3 PCDHA2 RAB3GAP1	4.28e-08	29	99	5	EFO_0008009
Disease	neutrophil count, basophil count	PCDHA9 PCDHA13 PCDHA3 PCDHA2 JMJD1C ATXN1 ZNF292	1.09e-05	224	99	7	EFO_0004833, EFO_0005090
Disease	atrial fibrillation	KDM3A CDHR3 JMJD1C CASZ1 LRIG1 ATXN1 ARHGAP21 ZNF292	3.67e-05	371	99	8	EFO_0000275
Disease	Abnormality of refraction	PCDHA9 ANK3 RBBP7 BACH1 PCDHA13 GRIA4 PCDHA3 PCDHA2 COBL AFF1	8.97e-05	673	99	10	HP_0000539
Disease	Hypoplastic Left Heart Syndrome	PCDHA9 PCDHA13	1.11e-04	5	99	2	C0152101
Disease	free cholesterol to total lipids in large LDL percentage	APOB JMJD1C AFF1 MACF1	1.15e-04	74	99	4	EFO_0022280
Disease	post-traumatic stress disorder symptom measurement	NSF PCDHA3 PCDHA2 CRHR1	1.71e-04	82	99	4	EFO_0008535
Disease	visceral adipose tissue measurement, body mass index	PCDHA9 PCDHA13 PCDHA3 PCDHA2	2.14e-04	87	99	4	EFO_0004340, EFO_0004765
Disease	platelet reactivity measurement, thrombus formation measurement	N4BP2 SETBP1	2.31e-04	7	99	2	EFO_0004985, EFO_0007615
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	WIPI1 APOB JMJD1C AFF1 MACF1 CDH3	3.43e-04	276	99	6	EFO_0004612, EFO_0020943
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	APOB JMJD1C AFF1 MACF1	4.09e-04	103	99	4	EFO_0008595, EFO_0020944
Disease	QRS complex, QRS duration	LRIG1 SETBP1 EPAS1	4.69e-04	45	99	3	EFO_0005054, EFO_0005055
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	WIPI1 APOB JMJD1C AFF1 MACF1 CDH3	6.02e-04	307	99	6	EFO_0004612, EFO_0020946
Disease	cholesteryl esters to total lipids in IDL percentage	APOB JMJD1C MACF1	6.40e-04	50	99	3	EFO_0022247
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	APOB JMJD1C AFF1	6.79e-04	51	99	3	EFO_0022302
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	APOB JMJD1C AFF1 MACF1	7.50e-04	121	99	4	EFO_0008595, EFO_0020943
Disease	sleep duration, high density lipoprotein cholesterol measurement	APOB JMJD1C COBL MACF1	7.50e-04	121	99	4	EFO_0004612, EFO_0005271
Disease	Disorder of eye	GPR179 ALMS1 VCAN CDH3 IMPG2	7.56e-04	212	99	5	C0015397
Disease	free cholesterol to total lipids in small LDL percentage	APOB JMJD1C AFF1	7.60e-04	53	99	3	EFO_0022286
Disease	multiple sclerosis	SLC6A16 CDHR3 SLAMF6 ATXN1 N4BP2 AFF1 CDH3 MYB	8.85e-04	594	99	8	MONDO_0005301
Disease	triglycerides in large VLDL measurement	APOB JMJD1C AFF1	8.93e-04	56	99	3	EFO_0022178
Disease	triglycerides in very large VLDL measurement	APOB JMJD1C AFF1	8.93e-04	56	99	3	EFO_0022325
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	APOB JMJD1C AFF1	8.93e-04	56	99	3	EFO_0022316
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	APOB JMJD1C AFF1 MACF1	8.98e-04	127	99	4	EFO_0008595, EFO_0020947
Disease	triglycerides in IDL measurement	APOB IZUMO1 AFF1	9.89e-04	58	99	3	EFO_0022149
Disease	phospholipids:total lipids ratio	WIPI1 APOB JMJD1C AFF1 MACF1	1.03e-03	227	99	5	EFO_0020946
Disease	triglycerides in VLDL measurement	APOB JMJD1C AFF1	1.04e-03	59	99	3	EFO_0022326
Disease	triglycerides to total lipids in small LDL percentage	APOB JMJD1C AFF1	1.04e-03	59	99	3	EFO_0022337
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	APOB JMJD1C AFF1	1.04e-03	59	99	3	EFO_0022260
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	APOB JMJD1C AFF1	1.09e-03	60	99	3	EFO_0021898
Disease	total lipids in VLDL measurement	APOB JMJD1C AFF1	1.09e-03	60	99	3	EFO_0022314
Disease	cholesterol to total lipids in IDL percentage	APOB JMJD1C MACF1	1.09e-03	60	99	3	EFO_0022233
Disease	triglycerides in small VLDL measurement	APOB JMJD1C AFF1	1.14e-03	61	99	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	APOB JMJD1C AFF1	1.14e-03	61	99	3	EFO_0022274
Disease	triglycerides in small HDL measurement	APOB JMJD1C AFF1	1.20e-03	62	99	3	EFO_0022158
Disease	phospholipids in large VLDL measurement	APOB JMJD1C AFF1	1.20e-03	62	99	3	EFO_0022169
Disease	triglycerides to total lipids in very large HDL percentage	APOB JMJD1C AFF1	1.20e-03	62	99	3	EFO_0022339
Disease	total lipids in chylomicrons and extremely large VLDL measurement	APOB JMJD1C AFF1	1.20e-03	62	99	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	APOB JMJD1C AFF1	1.20e-03	62	99	3	EFO_0022313
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	APOB JMJD1C AFF1	1.20e-03	62	99	3	EFO_0022263
Disease	phospholipids in very large VLDL measurement	APOB JMJD1C AFF1	1.20e-03	62	99	3	EFO_0022299
Disease	free cholesterol to total lipids in medium LDL percentage	APOB JMJD1C AFF1	1.26e-03	63	99	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	APOB JMJD1C AFF1	1.26e-03	63	99	3	EFO_0022292
Disease	cholesterol in large VLDL measurement	APOB JMJD1C AFF1	1.38e-03	65	99	3	EFO_0021902
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	APOB JMJD1C AFF1 MACF1 CDH3	1.39e-03	243	99	5	EFO_0004612, EFO_0020944
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	APOB JMJD1C AFF1 MACF1	1.43e-03	144	99	4	EFO_0004611, EFO_0020943
Disease	Hypogammaglobulinemia	CD55 IGHM	1.47e-03	17	99	2	C0086438
Disease	total lipids in large VLDL	APOB JMJD1C AFF1	1.50e-03	67	99	3	EFO_0022175
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	APOB JMJD1C MACF1	1.50e-03	67	99	3	EFO_0008595, EFO_0020946
Disease	triglycerides in very small VLDL measurement	APOB IZUMO1 AFF1	1.57e-03	68	99	3	EFO_0022144
Disease	triglycerides to phosphoglycerides ratio	APOB JMJD1C AFF1	1.57e-03	68	99	3	EFO_0022327
Disease	free cholesterol in large VLDL measurement	APOB JMJD1C AFF1	1.57e-03	68	99	3	EFO_0022265
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	APOB JMJD1C AFF1 MACF1	1.66e-03	150	99	4	EFO_0004611, EFO_0020947
Disease	triglycerides to total lipids in small HDL percentage	APOB JMJD1C AFF1	1.85e-03	72	99	3	EFO_0022336
Disease	diastolic blood pressure, systolic blood pressure	ANK3 BACH1 CASZ1 ALMS1 LRIG1 N4BP2 SETBP1 AFF1	1.90e-03	670	99	8	EFO_0006335, EFO_0006336
Disease	white matter microstructure measurement	NSF APOB VCAN SETBP1 SCAPER ARHGAP21	2.05e-03	390	99	6	EFO_0005674
Disease	docosahexaenoic acid to total fatty acids percentage	APOB JMJD1C	2.24e-03	21	99	2	EFO_0022262
Disease	neutrophil count	PCDHA9 PCDHA13 PCDHA3 PCDHA2 JMJD1C CASZ1 ATXN1 GUSB BEND7 AFF1 MYB ZNF292	2.28e-03	1382	99	12	EFO_0004833
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	APOB JMJD1C AFF1	2.32e-03	78	99	3	EFO_0022187
Disease	basophil percentage of granulocytes	JMJD1C AFF1 MYB	2.77e-03	83	99	3	EFO_0007995
Disease	vital capacity	PCDHA9 PCDHA13 PCDHA3 PCDHA2 APOB JMJD1C CASZ1 GUSB AFF1 ASPSCR1 DUSP10	2.89e-03	1236	99	11	EFO_0004312
Disease	Anhedonia	ANK3 CRHR1	2.93e-03	24	99	2	C0178417
Disease	neuroticism measurement, cognitive function measurement	PCDHA9 PCDHA13 PCDHA3 PCDHA2 JMJD1C N4BP2 USP33	3.00e-03	566	99	7	EFO_0007660, EFO_0008354
Disease	liver fibrosis measurement	APOB JMJD1C MYB	3.06e-03	86	99	3	EFO_0010576
Disease	Left ventricular mass to end-diastolic volume ratio	NSF PXN	3.18e-03	25	99	2	EFO_0010556
Disease	Malignant neoplasm of breast	KDM3A CRHR1 GGA3 PHKB NSUN6 N4BP2 BEND7 SETBP1 AFF1 MACF1	3.27e-03	1074	99	10	C0006142

Protein segments in the cluster

Peptide	Gene	Start	Entry
HISVKEPTPSIASDI	ESYT2	746	A0FGR8
VSPPHVSTFKTRSAK	EPAS1	671	Q99814
TEKSEVTPFPHNSSI	BACH1	301	O14867
THCSVTLKPAPFTSE	CFAP54	916	Q96N23
TPPKTVLDDHTQTLF	ASPSCR1	436	Q9BZE9
VDLSKPVSTVPQFAH	VCAN	931	P13611
STAHLETKATILPLP	CASZ1	281	Q86V15
KTVLPTALPSSFSHR	ALMS1	2131	Q8TCU4
DLSPISKGFHTIPST	CACNG3	246	O60359
SSDVPHVVPCKFTIS	CFAP92	66	Q9ULG3
AAVPHTFVTTALPKS	ATXN1	516	P54253
KHTTPFSVSDILSPL	NKX2-1	6	P43699
THALSKLTEPASVPI	RAB3GAP1	361	Q15042
TCSLTPHVPFKLVST	PCDHA9	386	Q9Y5H5
TCSLTPHVPFKLVST	PCDHA2	386	Q9Y5H9
AISPVTSPLHLKSSL	PCDH19	1061	Q8TAB3
TEHTLPFTSPDKTLA	MUC16	51	Q8WXI7
TIPTVSKTTPNFFHS	MUC16	10606	Q8WXI7
TFPTLTKSPHETETR	MUC16	10666	Q8WXI7
TPKFSHSKSDTTLPV	MUC16	11506	Q8WXI7
TCSLTPHVPFKLVST	PCDHA3	386	Q9Y5H8
KHTTPFSVSDILSPI	NKX2-4	6	Q9H2Z4
ISTSPPLIHSFVSKV	MUC15	106	Q8N387
NVLPSFTKTPHDITI	LRIG1	596	Q96JA1
VFSFPSLPKDLLHTT	NEUROG1	216	Q92886
HSTVTTTLALIFIPK	GPR179	616	Q6PRD1
TVSQIKSPFTTHVAP	HIPK1	551	Q86Z02
AVSTHPSIVKETLPL	MMS19	561	Q96T76
FHPIPTRSSTLETTK	JMJD1C	686	Q15652
TPVSRTTKHFHETTP	CD55	331	P08174
SHPPVIATTVVSLKA	DUSP10	41	Q9Y6W6
VTAVKFTISDHPQPI	CAND1	986	Q86VP6
VKFASTVFPSDHIPS	ECPAS	501	Q5VYK3
SALHISLITPSFPTE	GRIA4	111	P48058
PHKQFSTSSIDLTPL	GRID2	891	O43424
IHTTTSPTPVFTTLK	MUC3A	236	Q02505
LVTVTESFSTPKFHI	PECAM1	226	P16284
PLPSSLSCKVHVASV	MVD	101	P53602
TISPFFEPIDTKLSH	MANSC4	231	A6NHS7
TFTLKTHPSVVPGSI	NSF	46	P46459
LASIHVPLESIKPSS	GGA3	581	Q9NZ52
STPLIGHKLTVTTPF	MYB	421	P10242
VSPQPLSSDHVKVFL	NLK	231	Q9UBE8
LHPSDDSIKVIPLTT	PCDH11X	1311	Q9BZA7
TLLKHLSHPPSFTTV	NSUN6	41	Q8TEA1
THTSFLTEPLKGAIP	PEG3	1316	Q9GZU2
PSVPSTKEELTLEHF	LRIT1	396	Q9P2V4
HFTSLELVPPSTLTT	MACF1	531	Q9UPN3
ELVPPSTLTTTHLKA	MACF1	536	Q9UPN3
PHIIATKTPSSDVLV	RBBP7	136	Q16576
TCTLTPHVPFKLVST	PCDHA13	386	Q9Y5I0
TASSVTKPPHFILTT	PARP12	361	Q9H0J9
SHISKRPVFLSEETP	PXN	16	P49023
KAVHFSPVSSLPDTS	GLYATL3	131	Q5SZD4
ITSPISLASPKEIDH	PAPOLG	21	Q9BWT3
TLHLVSTTKTEVIPP	APOB	941	P04114
LPPLSKSSTVLHTFN	KDM3A	856	Q9Y4C1
FTCTVTHTDLPSPLK	IGHM	301	P01871
SHYPISVKVPDSITT	C3P1	26	Q6ZMU1
ISSTLVPSKHPLFTQ	CEP97	656	Q8IW35
GTVTLSIKVIPHPTT	CDHR3	671	Q6ZTQ4
SIKVIPHPTTIITTT	CDHR3	676	Q6ZTQ4
VIAHTKSLDPSRPVT	GUSB	466	P08236
PPQKVVAHTEFTTSS	CRACD	806	Q6ZU35
SETGLLSSFPVKVHP	CDON	546	Q4KMG0
LSSFPVKVHPSAVES	CDON	551	Q4KMG0
VPAAHTTEVTFLKPQ	COBL	846	O75128
SSFVPFITEHIIKPD	EBI3	116	Q14213
ALLSPIKTLTTETHP	ANK3	1851	Q12955
IKTLTTETHPQPHFS	ANK3	1856	Q12955
IPTSPTRVSFHSIKQ	CRHR1	426	P34998
HPISSTKFRKPSVAT	MCHR1	216	Q99705
APAPSTVHFKSLSDT	KLF10	111	Q13118
TSSKIPSITDPHFID	GLIPR1L1	21	Q6UWM5
FPTPGSAKSLTLHIS	BEND7	501	Q8N7W2
SPATIINFHVTVLPK	IZUMO1	241	Q8IYV9
TIPSLFLPKETEHSF	CEP295	1641	Q9C0D2
LFHGTILDPSTASPK	SCAPER	1191	Q9BY12
TSPHSGAFLLSPTKL	POLRMT	656	O00411
THPSFTSESTKQPKL	POLB	196	P06746
FVLKLPTSTATIVVH	CDH3	416	P22223
KFSSSIAPHITTFLV	PHKB	791	Q93100
LEPETAPTKSLVSHI	PRR14L	1576	Q5THK1
VLKHSVPLPTELSSE	APOOL	216	Q6UXV4
ETPHALTVSPFKAFS	KIF13A	1446	Q9H1H9
TSLPLSHQLTPSKEV	SLC6A16	701	Q9GZN6
SLAFIVPHETKSPEI	SLAMF6	61	Q96DU3
SPSSPSVEHFTLRVK	TMEM132E	321	Q6IEE7
FTVISVPHLPEKQAT	SNX33	281	Q8WV41
QLTVPSHTDPVSIFK	SLC26A3	231	P40879
ESASLTLPKHISEVP	IMPG2	696	Q9BZV3
LSLLPKSTPNVTSFH	MRPL47	36	Q9HD33
HNVSASTTPKLPEVV	BRPF1	166	P55201
LTAIHTPSTAEPSKF	AFF1	371	P51825
DTRVIHIKTSTVPPS	ATF6B	651	Q99941
VTKPPVISSHFTQDF	ZNF99	71	A8MXY4
KPPTSQSSVLSHLDF	UBAP2	411	Q5T6F2
SVTHPKDISVAPRTL	USPL1	546	Q5W0Q7
FKTSLESHTVLAPLT	ZNF292	1706	O60281
KVFSFPAPSHVVTAT	TEX264	121	Q9Y6I9
HPIIPEQSTFKVLST	SUGT1	226	Q9Y2Z0
LFSSSLVVVVSHTKP	WIPI1	66	Q5MNZ9
KPTTSHFSVLSFTPR	SIGLEC10	191	Q96LC7
LKAPSTHVTKPSFSQ	ARHGAP21	626	Q5T5U3
DSSHVRITIPIKAPS	SETBP1	396	Q9Y6X0
STKISTHVSFPLEGL	USP33	626	Q8TEY7
AFVPITSSTDPAHTK	TTLL5	1266	Q6EMB2
TFPPSVISHTSPTKV	N4BP2	396	Q86UW6
HPDTLKFTSIVDSPV	NEB	1231	P20929